Stage IIIC Esophageal Adenocarcinoma
4 clinical trials · Condition
◉ Watch Stage IIIC Esophageal Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Molecular Phenotyping in Predicting Response in Patients With Stage IB-III Esophageal Cancer Receiving Combination Chemotherapy (NCT02392377) | Case Comprehensive Cancer Center | 2015-02-01 |
| Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer (NCT02366819) | University of Chicago | 2014-12-11 |
| Regorafenib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction Who Have Completed Chemoradiation Therapy and Surgery (NCT02234180) | Academic and Community Cancer Research United | 2014-09-01 |
| Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer (NCT01178944) | Roswell Park Cancer Institute | 2010-09-01 |
Track Stage IIIC Esophageal Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.